US 9475839
Peptide-based inhibitor of interleukin-10 or interferon-gamma signaling
granted A61PA61P31/16A61P31/18
Quick answer
US patent 9475839 (Peptide-based inhibitor of interleukin-10 or interferon-gamma signaling) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Oct 20 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Oct 25 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 20 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61P, A61P31/16, A61P31/18, A61P31/20, A61P35/00